In Alzheimer's disease (AD), a lack of adiponectin was associated with AD-related pathology including phosphorylated Tau, amyloid-β (Aβ) buildup, neuroinflammation and impaired neuronal function (28). This evidence concerns the gene MAPT and Alzheimer disease.